- Cancer Biology
- Chromatography & Mass Spectrometry
- Contract Research
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & Rapid Micro Methods (RMMs)
- Process Analytical Technology (PAT) & Quality by Design (QbD)
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Latest News
- Contact us
The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Caroline Richards on +44 (0)1959 563311 or email us.
Posted on: 25 November 2014 | Source: Cobalt Light Systems
Cobalt Light Systems is pleased to announce that a major pharmaceutical company has gained regulatory approval to release products using Cobalt’s TRS100 instrument instead of by HPLC...
Posted on: 25 November 2014 | Source: Graeme Cathie, European Pharmaceutical Review
Graeme Cathie speaks with Jennifer Garrett, Regional Business Manager, BioPharma, bioMérieux at the PDA conference on Pharmaceutical Microbiology...
European Commission approves Rezolsta, a new once-daily, fixed-dose HIV therapy combining darunavir and cobicistat
Posted on: 25 November 2014 | Source: Janssen
Janssen-Cilag International NV announced that the European Commission (EC) has approved the use of REZOLSTA® (darunavir/cobicistat) in combination with other antiretroviral (ARV) medicinal products for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years or older...
Posted on: 25 November 2014 | Source: Promethera Biosciences
Promethera Biosciences, a Belgian biotechnology company developing Promethera® HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital...
Posted on: 25 November 2014 | Source: Braun
Nationwide consumer survey sponsored by Braun discovers that regular blood pressure measurement must become a higher priority...
Posted on: 25 November 2014 | Source: Roche
Roche is increasing the payroll for its workforce of over 13,000 in Switzerland by 1.4 percent with effect from 1 April 2015...
Posted on: 25 November 2014 | Source: Frost & Sullivan
Frost & Sullivan profiles key medical device manufacturers in the region, where the market is expected to grow at a CAGR of 3.1 percent between 2014 and 2018...
Posted on: 24 November 2014 | Source: Bioquell
The Bioquell wound treatment system, BioxyQuell, has been tested at a wound care clinic in Hampshire with patients suffering from long term chronic venous leg ulceration. The results, presented in two case studies, show how aqueous oxygen peroxide (AOP) applied using the BioxyQuell system reduced odours and pain as well as improved wound healing...
Posted on: 24 November 2014 | Source: Lucideon
Lucideon, the international provider of materials development, testing and assurance, has launched a new Composites Information Service.
Posted on: 24 November 2014 | Source: Dr. Yongqiang Zhang, Senior Scientist, BD Diagnostics
This online discussion will demonstrate how a rapid method can provide a solution to a common microbiological testing problem for pharmaceutical manufacturers – process water microbiology testing...
Posted on: 24 November 2014 | Source: Doctors of the World UK
Doctors of the World UK is to run a 100-bed Ebola treatment centre in Sierra Leone that’s being custom-built in a town called Moyamba...
Posted on: 24 November 2014 | Source: Enanta Pharmaceuticals, Inc.
Enanta announces CHMP positive opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA™ (dasabuvir) for the treatment of chronic hepatitis C in Europe...